Price | 4350€+ Login to see price |
Organism | Human |
Product Type | Organoid |
Tissue | iPSC |
Disease | – |
Applications
Toxicity
Organoid Based
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
We successfully developed retinal organoids from human pluripotent stem cells (hPSCs) using advanced differentiation technology.
The human retina can be broadlydivided into the Neural Retina and Retinal Pigmented Epithelium. We confirmed the expression of specific markers present in each layer of the retina in theretinal organoids. Around 25 days of cultivation, the presence of Retinal Ganglion Cells and Bipolar Cell layers was observed, along with the expression of the specific marker Paired Box Protein-6 (Pax6). Furthermore, by observing changes in cell arrangement within the organoid andexamining the marker for photosensitive cells (Recoverin), we confirmed thesimilarity of the produced retinal organoid to human tissue.
Lambda Biologics GmbH
Deutscher Platz 5 c, 04103, Leipzig, Germany
info@lambdabiologics.com
